Prevention of nausea and vomiting in female patients undergoing breast surgery: a comparison with granisetron, droperidol, metoclopramide and placebo.

Breast surgery is associated with a relatively high incidence of postoperative nausea and vomiting (PONV). This study was undertaken to evaluate the efficacy of granisetron, droperidol and metoclopramide for preventing PONV after breast surgery.
In a randomized, double-blind, placebo-controlled trial, 120 female patients received granisetron 40 micrograms.kg-1, droperidol 1.25 mg, metoclopramide 10 mg or placebo (saline) (n = 30 for each) intravenously immediately before the induction of anaesthesia. A standard general anaesthetic technique was employed throughout. Postoperatively, during the first 24 h after anaesthesia, the incidence of PONV and adverse events was recorded.
The incidence of PONV was 17% with granisetron, 37% with droperidol, 43% with metoclopramide and 50% with placebo (P < 0.05; overall Fisher's exact probability test). The incidence of adverse events was not different among the groups.
Granisetron is highly effective for reducing the incidence of PONV in female patients undergoing breast surgery. Droperidol and metoclopramide are ineffective in this population.
AuthorsY Fujii, H Tanaka, H Toyooka
JournalActa anaesthesiologica Scandinavica (Acta Anaesthesiol Scand) Vol. 42 Issue 2 Pg. 220-4 (Feb 1998) ISSN: 0001-5172 [Print] DENMARK
PMID9509207 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Retracted Publication)
Chemical References
  • Antiemetics
  • Metoclopramide
  • Droperidol
  • Granisetron
  • Adult
  • Antiemetics (therapeutic use)
  • Breast Neoplasms (surgery)
  • Double-Blind Method
  • Droperidol (therapeutic use)
  • Female
  • Granisetron (therapeutic use)
  • Humans
  • Metoclopramide (therapeutic use)
  • Middle Aged
  • Nausea (prevention & control)
  • Postoperative Complications (prevention & control)
  • Vomiting (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: